Joseph F. Hokello

Salutation
Dr.
First Name
Joseph
Middle Name
F.
Last Name
Hokello
Qualification
Ph.D., Molecular Virology, Case Western Reserve University, Ohio, USA.
Job Title
Senior Lecturer
Campus
Nagongera
Office Hours
8:00am-5:00pm
profile picture
profile picture
Attach CV
Biography

Dr. Joseph F. Hokello is a Molecular Biologist/Virologist with enormous research experience focusing on HIV basic research for HIV prevention in developing countries and globally.  He is a Professional Science educator with pedagogical skills required to enhance teaching and comprehension of Science’s complex concepts. Dr. Joseph F. Hokello is the acting Head of Biology department, Faculty of Science and   Education and a Senior Lecturer in the same department. Dr. Joseph F. Hokello has a vast experience both in academia and administration i.e. he was an Associate Dean in charge of Research and Innovations, Faculty of Science and Technology, Kampala International University-Western Campus. He was a Research Co-coordinator for the Faculty of Science and Technology, Kampala International University-Western Campus, Senior Lecturer in the Department of Basic Science, Microbiology and Immunology at Faculty of Science and Technology and Biomedical Sciences respectively at Kampala International University-Western Campus. He was Lecturer at Makerere University in the Master of Science in Molecular Biology and Biotechnology Program. He was also a Post-Doctoral trainee in the Department of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America

Publications and Papers
  • Wandera A, Ssekatawa K, Kato C.D and Hokello J (2022). Centrifugation  following HIV-1 Virion Lysis improves the Sensitivity of the Fourth-Generation  HIV Ag/Ab Combo Assay. (In Preparation) 
  • Hokello J (2022). Dietary approach to prevention of cardiovascular diseases: A  personal practical handbook. (In Preparation) 
  • Hokello J, Sharma AL and Tyagi M (2022). Insights into HIV Molecular  Biology, HIV-induced Th1/Th2 Shift and Preferential Virus infection of Th2  Cells. (In Preparation) 
  • Hokello J, Sharma AL and Tyagi M (2022). T-cell receptor activation using α- CD3mAb without α-CD28mAb co-stimulation activates HIV latency through  functional synergy between NFAT and AP-1. (In Preparation) 
  • Hokello J, Sharma AL and Tyagi M (2022). Comparison of biological basis for  non-HIV transmission to HIV-exposed seronegative individuals, disease non progression in HIV long-term non-progressors and elite suppressors. (In  Preparation) 
  • Hokello J, Sharma AL, Tyagi P, Bhushan A and Tyagi M (2021). Human  Immunodeficiency Virus type-1 (HIV-1) transcriptional regulation, latency and  therapy in the Central Nervous System. Vaccines, 9 (11): 1272 
  • Sharma AL, Hokello J and Tyagi M (2021). Acquisition of HIV in the mal genital  tract and circumcision as an intervening strategy. Pathogens, 10 (7): 806 
  • Hokello J, Sharma AL and Tyagi M (2021). An update on the HIV DNA vaccine strategy. Vaccines, 9 (6): 605 
  • Hokello J, Sharma AL and Tyagi M (2021). Combinatorial use of both epigenetic  and non-epigenetic mechanisms to efficiently reactivate HIV latency. Int. J. Mol.  Sci., 22 (7): 3697 
  • Hokello J, Sharma AL and Tyagi M (2021). AP-1 and NF-κB synergize to  transcriptionally activate latent HIV upon T-cell receptor activation. FEBS Letters, 595 (5): 577-594 
  • Hokello J, Sharma AL, Shukla GC and Tyagi M (2020). A narrative review on the  basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of  COVID-19. Annals of Translational Medicine, 8 (24): 1686 
  •  Sharma AL, Hokello J, Sonti S, Zicari S, Sun L, Alqatawni A, Bukrinsky M,  Simon G, Chauhan A, Daniel R and Tyagi M (2020). CBF-1 promotes the  establishment and maintenance of HIV latency by recruiting Polycomb repressive  complexes, PRC1 and PRC2, at HIV LTR. Viruses, 12 (9): 1040 
  • Hokello J, Sharma AL and Tyagi M (2020). Efficient non-epigenetic activation  of HIV latency through the T-cell receptor signalosome. Viruses, 12 (8): 868 
  • Hokello J, Sharma AL, Dimri M and Tyagi M (2019). Insights into the HIV   latency and the role of cytokines. Pathogens, 8 (3): 137 
  • Kim YK, Mbonye U, Hokello J, and Karn J (2011). T-cell receptor signaling  enhances transcriptional elongation from latent HIV proviruses by activating P TEFb through an ERK-dependent pathway. Journal of Molecular Biology, 410 (5): 896-916  
  • Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, and Karn J  (2008). Epigenetic silencing of human immunodeficiency virus transcription by  formation of restrictive chromatin structures at the viral long terminal repeat
  • drives the progressive entry of HIV in to latency. Journal of Virology, 84 (24): 
  • 12292-303. 
  • Kajumbula H, Wallace RG, Zong JC, Hokello J, Sussman N, Simms S,  Rockwell RF, Pozos R, Hayward GS and Boto W (2006). Ugandan Kaposi’s  sarcoma-associated herpesvirus phylogeny: evidence for cross-ethnic transmission of viral subtypes. Intervirology, 49 (3): 133-43.  
Professional Appointments

Senior Lecturer

AG. Head of Biology Department

Research Focus
  • Cell Biology
  • Molecular Biology
  • HIV a/ AIDS
  • Fundamental
  • Pathogenicity.
Courses Taught
Protein Biotechnology
Fundamental Immunology
Medical Virology
Parasite Biochemistry, Physiology and Immunology
Molecular Biology
Research Methodology
Microbiology and Immunology
Microbiology and Mycology
Applied genetics
Molecular Biology Techniques
Cell Biology
Advanced Animal Physiology
Plant Physiology
Applied Genetics
Principles of Ecology Evolution
Staff Type
Academic Staff